Table 2.

Comparison of SRE between the two groups.

Type of SRE	All (N = 95)	ICIs (n = 53)	ICIs + Antiangiogenic agents (n = 42)	p
All SRE	31 (32.6%)	19 (35.8%)	12 (28.6%)	.425
Pathological fractures	12 (12.6%)	8 (15.1%)	4 (9.5%)	.417
Spinal cord compression	3 (3.2%)	1 (1.9%)	2 (4.8%)	.426
Surgery	6 (6.3%)	4 (7.5%)	2 (4.8%)	.579
Palliative bone radiotherapy	10 (10.5%)	6 (11.3%)	4 (9.5%)	.777
SRE after ICIs	22 (23.2%)	15 (28.3%)	7 (16.7%)	.182

SRE, skeletal-related event; ICIs, immune checkpoint inhibitors.